Tag | Content |
---|
EnhancerAtlas ID | HS052-36834 |
Organism | Homo sapiens |
Tissue/cell | Fibroblast_foreskin |
Coordinate | chr8:41996950-41998960 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
RFX1 | MA0509.2 | chr8:41997879-41997895 | CGTCACCATGGCAACC | + | 7.02 | RFX1 | MA0509.2 | chr8:41997879-41997895 | CGTCACCATGGCAACC | - | 7.02 | RFX2 | MA0600.2 | chr8:41997879-41997895 | CGTCACCATGGCAACC | + | 7.04 | RFX2 | MA0600.2 | chr8:41997879-41997895 | CGTCACCATGGCAACC | - | 7.28 | RFX5 | MA0510.2 | chr8:41997879-41997895 | CGTCACCATGGCAACC | - | 7.02 | RFX5 | MA0510.2 | chr8:41997879-41997895 | CGTCACCATGGCAACC | + | 7 |
|
| Number of super-enhancer constituents: 22 | ID | Coordinate | Tissue/cell |
SE_10617 | chr8:41996742-42000638 | CD19_Primary | SE_11527 | chr8:41996399-42001420 | CD20 | SE_11958 | chr8:41996681-42001675 | CD3 | SE_12998 | chr8:41996662-42001195 | CD34_Primary_RO01480 | SE_13586 | chr8:41996283-42002252 | CD34_Primary_RO01536 | SE_14125 | chr8:41996516-42001382 | CD34_Primary_RO01549 | SE_14499 | chr8:41996655-42002299 | CD4_Memory_Primary_7pool | SE_15439 | chr8:41996577-42001146 | CD4_Memory_Primary_8pool | SE_15838 | chr8:41996734-42001407 | CD4_Naive_Primary_7pool | SE_16334 | chr8:41996804-42001135 | CD4_Naive_Primary_8pool | SE_16963 | chr8:41996692-42001266 | CD4p_CD225int_CD127p_Tmem | SE_17422 | chr8:41996437-42002582 | CD4p_CD25-_CD45RAp_Naive | SE_17925 | chr8:41996376-42001954 | CD4p_CD25-_CD45ROp_Memory | SE_18335 | chr8:41996168-42006983 | CD4p_CD25-_Il17-_PMAstim_Th | SE_19215 | chr8:41996645-42001482 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_20189 | chr8:41996609-42001489 | CD56 | SE_20868 | chr8:41996560-42001475 | CD8_Memory_7pool | SE_21518 | chr8:41996610-42001381 | CD8_Naive_7pool | SE_22029 | chr8:41996575-42001644 | CD8_Naive_8pool | SE_22476 | chr8:41996473-42002144 | CD8_primiary | SE_38500 | chr8:41996634-42001102 | HUVEC | SE_62846 | chr8:41996602-42040825 | Tonsil |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | GGAGAGTGGC ACATCTCATT AGACAGTGTT CAAGCAAATG CAACTTTATT TCAAAGTTCT 60 TTTTTCTTTA CAGGTAAAGA CATAGTATAA ACGGCAAAAT TCAAAAGGTG CAGAAGATTC 120 TAGTACGGTG AAAAGCAAGT TTTCTTTCTC TCCTCCACTC CTAGTCCCAC AGTGACCATC 180 CTAAGAAGCA ACCACTTCCA GAGATGCAAA CACACATACC ACATACACAC AGCCCTACTC 240 ACACTCTTCT GCACTTTATT ACTTAGAATA CACCGGAAAA TTTCCACGTC TCAGCAAATA 300 CAGCTGCCCT GTACTCTTTA ATGGCAGCTT AGTGTTCCCT CAGAGGGATG CGCCCCATAT 360 CATTCACCCA GCCCCCAGGG ACGGGCTTTT AGGTTGTTTC CAGCTGCTTG CTCTTACAAG 420 CAACATTGCA ACGCTGCCCT GTTACTTTTA ATCTTCTTTA TCCTGTGATT CCGTTCTGCT 480 TTTCCTTCCA GCACGACTGC AAAGTGACTG CGGGGTTTTC CCGAGTGCCC TCGCCCCAGA 540 CCTCAGCGAG TTATTTGTGG AGTCACCGGG TCCTGCTCCG CATTGTTATT CGAAGTCTCC 600 CCGGGACAGC GGGGAGCAGG CGGAGCTGCG TGTCCCGGCC TGCGCGTCTG GGCCCAGGCG 660 GGCGCGCGTC GCGCTCGGAT TTCGGGCGGA TAGTGCGTGG GAGGCGGCGC TGCCCTCCGT 720 ATGCAGCGCG CGTGCAGCCA AGGCGGCGCT GCGATCTGCG GCCTGGGGCC CTGGTGTGAA 780 ACTCCCGCGG AGACGCTCCC AGCCCCGGGC CGCAGCTCGC CCCTGCACGG AGGGAGGTGT 840 CTAAAGGTGT CTCTTAGGAA CAGGCACAAC CCGAGCAGCC GGGCCCCAGA ACAATGGGTG 900 CTTTCAGCCG CCCCTTTAGA TGCCTGGCCC GTCACCATGG CAACCACCCC ATTATTGAAA 960 GTCAGTGCCG GTCCCCGCCT TAGACGCTCT CCTCCCGGGC TCCCCTCCCC CGCCGGCCCC 1020 GCCGTATGGT GTGTGTGTCA CTGGCAGCTG TTGTCAAAAG AAGGCACCTC TTTGTCTCCA 1080 GGGGATGAAA GCCATTTGGT TTCCAGCGCC ACCCTTTCTC TCCGCCCGGC AACTTTTCTC 1140 CGCGTCCCGT CCCCAAGGCG TCCCTGGATG CGCGCGCTCG GCCCCGCGCC CGCCACCCGC 1200 GCTGAGTGCT GGTATCCTCC CCATCACTCA GCCCAGAGCC GTTCTGCCTC TGCCTCAAAC 1260 TCTCAGAGTC CTTATAAGTC TTATTCTCAA GAGTTGTGTC CCAGCGAAGG GAATCCGCCT 1320 TGGAAATCGC GGCTTCCTCC TTGCACGCCG CTCGCTGTTT CAGCGCAAGC CGGATCTCCC 1380 CTCACACCCA ACAGCACCAC CTTCCGAGAC TAGCGGCTCA TTACCGCCCA GTCCCCGCGG 1440 CCGGCGCAAG AACTCCTCGC CGGGCCCCAT TCCAGGCTGG GTCGGGTCTT TAGAATAAGG 1500 ACCAGTTGTG TGTCTCCCTG TCGCTGGCAG CGGATCACTT TCTGGCTGAA GAAAAGACAA 1560 AACGACGAGG GAAACAATAG GACCTGTATG TTTTACACAC AGTTCTCATT CGAAATGTAT 1620 CATGATCATA TTTTTAAAGA TGCGTGTTAC CTTTCATAAA TACCTAAATA AAACTTACTT 1680 TCTGTTGTCT GCGGAGGAAC TTGATAAACA TTAAAAAAGC AAGAATATCT TTGGTGGCCA 1740 TGTGTCTGGG ATGTGGGGTT CACCTATCAT CTGCCCCAGG GATCCTAAGA GGGGAACAGA 1800 TGGTGTTTTC AAAACCTATC TGGAAATTAA AAAGGTTACG GTGCTGAGAG GAAGAGCAGA 1860 GTCCAAGAGG AGGGGGCTGT GAGAGAGAAA CGCAGAGAGA GGATAAAGCT AGGACTTCCA 1920 GTTATTCTGT AAAGACAAAC TTGAGATGCT GTGTGGGTAG GAAAAATAGA GGCGTCATAA 1980 AACTTCACTG ATACTGAAAA GTGTAACTAC 2010
|